Pelage Pharmaceuticals, Inc.
3 private offerings reported to the SEC on Form D since 2016, $150.7M sold in all. Pharma, CA.
- Form D offerings: 3
- Reported sold: $150.7M
- Newest: Nov 24, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Nov 24, 2025 | $120.0M | $120.0M | Pelage Pharmaceuticals, Inc.Pharma · CA | Not amended | 0001982875-25-000002 |
| Aug 23, 2024 | $14.0M | $14.0M | Pelage Pharmaceuticals, Inc.Pharma · CA | Not amended | 0001982875-24-000002 |
| Jun 28, 2023 | $16.7M | $16.7M | Pelage Pharmaceuticals, Inc.Pharma · CA | Not amended | 0001982875-23-000001 |
SEC Profile
From the company's EDGAR record- Business address
- Los Angeles, Ca
- Incorporated in
- DE
- All SEC filings
- CIK 1982875 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR